Auravax Therapeutics logo

Auravax Therapeutics Headquarters & Office Locations

Verified data Biotechnology 3 employees

Data last updated · Sourced via GraphIQ

Headquarters
—
Total locations
—
recorded by GraphIQ
Employees
3
est. 2026

Auravax Therapeutics headquarters details

About Auravax Therapeutics

Auravax Therapeutics: Biotechnology company offering COVID-19 vaccines. Founded in 2020, the company employs approximately 3 people worldwide.

What does Auravax Therapeutics do?

AuraVax Therapeutics, Inc. is a privately held biopharmaceutical company developing NanoSTING for the treatment and prevention of upper respiratory disease due to all major viral pathogens. This platform activates the STING pathway to trigger an effective innate immune response upon intranasal delivery. We are developing NanoSTING for global access to address the disease burden of current respiratory viruses and future emerging pathogens.

Frequently asked questions

When was Auravax Therapeutics founded?

Auravax Therapeutics was founded in 2020 and employs approximately 3 people.

How many employees does Auravax Therapeutics have?

Auravax Therapeutics has approximately 3 employees (GraphIQ estimate, 2026).

Find more info on Auravax Therapeutics using GraphIQ

Revenue teams waste hours stitching together data from a dozen tools before a single rep can make a meaningful touch. GraphIQ fixes that. Whether you're building target account lists, routing inbound leads, or keeping your CRM clean as Auravax Therapeutics's structure evolves, GraphIQ gives you verified company, people and location data in one place.

From territory planning and lead scoring to handoff workflows and pipeline hygiene, our platform connects the data your GTM engine needs to run without friction. Sign up today and see how GraphIQ helps your revenue team spend less time finding information and more time acting on it.

300M+Companies tracked
370M+Employees
2TNews articles & events